| 2868 |
1350: Increased, glutamate |
2123: decreased, Bcl-2 |
Apr 4, 2023 |
Apr 4, 2023 |
1 AOP
|
| 2869 |
1350: Increased, glutamate |
2124: increased, Bax |
Apr 4, 2023 |
Apr 4, 2023 |
1 AOP
|
| 1206 |
1158: Increased, Hepatic thyroid hormone uptake/transport |
401: Increase, Biliary excretion TH glucuronide |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2237 |
1158: Increased, Hepatic thyroid hormone uptake/transport |
281: T4 in serum, Decreased |
Dec 9, 2020 |
Dec 9, 2020 |
3 AOPs
|
| 2479 |
1158: Increased, Hepatic thyroid hormone uptake/transport |
961: Increased, Clearance of thyroxine from serum |
Sep 10, 2021 |
Sep 10, 2021 |
3 AOPs
|
| 803 |
802: Increased, HIF-1 alpha transcription |
799: Increased, HIF-1 heterodimer |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 800 |
799: Increased, HIF-1 heterodimer |
800: Decreased, Aromatase (Cyp19a1) mRNA |
Nov 29, 2016 |
Dec 3, 2016 |
2 AOPs
|
| 1459 |
1362: Increased, hippocampal hyperdepolarization |
1348: Increase, seizure |
Apr 14, 2017 |
Apr 14, 2017 |
1 AOP
|
| 1549 |
1362: Increased, hippocampal hyperdepolarization |
1344: Increased, seizure |
Jun 2, 2017 |
Jun 2, 2017 |
2 AOPs
|
| 3118 |
2206: Increased, histomorphological alteration of testis |
1758: Impaired, Spermatogenesis |
Jan 24, 2024 |
Apr 11, 2024 |
1 AOP
|
| 1068 |
1025: Increased, Hyperplasia (follicular cells) |
1026: Increased Apoptosis, Adenomas/carcinomas (follicular cell) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2426 |
1025: Increased, Hyperplasia (follicular cells) |
741: Increase, Adenomas/carcinomas (follicular cell) |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 1107 |
1069: Increased, Hyperplasia (glandular epithelial cells of endometrium) |
1070: Increased, adenosquamous carcinomas of endometrium |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1123 |
1085: Increased, hyperplasia (mammary gland) |
1080: Increased, latency period |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1124 |
1085: Increased, hyperplasia (mammary gland) |
1079: Increased, Adenomas/carcinomas (mammary) |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1067 |
1024: Increased, Hypertrophy and proliferation (follicular cell) |
1025: Increased, Hyperplasia (follicular cells) |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 2427 |
1024: Increased, Hypertrophy and proliferation (follicular cell) |
740: Increase, Hyperplasia (follicular cells) |
Jul 7, 2021 |
Jul 7, 2021 |
None
|
| 342 |
376: Increased, Induced Mutations in Critical Genes |
377: Increased, Proliferation/Clonal Expansion of Mutant Cells (Pre-Neoplastic Lesions/Altered H |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 346 |
376: Increased, Induced Mutations in Critical Genes |
378: Tumorigenesis, Hepatocellular carcinoma |
Nov 29, 2016 |
Nov 30, 2016 |
1 AOP
|
| 351 |
376: Increased, Induced Mutations in Critical Genes |
384: Increased, Clonal Expansion / Cell Proliferatin to form Pre-Neoplastic Altered Hepatic Foci |
Nov 29, 2016 |
Nov 29, 2016 |
None
|
| 549 |
376: Increased, Induced Mutations in Critical Genes |
491: Clonal Expansion/Cell Proliferation, to form Altered Hepatic Foci (AHF) |
Nov 29, 2016 |
Nov 29, 2016 |
1 AOP
|
| 891 |
376: Increased, Induced Mutations in Critical Genes |
872: Increase, Site of Contact Nasal Tumors |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 762 |
726: Increased, Induction of pyruvate dehydrogenase (PDH) |
769: Increase, Oxidative metabolism |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|
| 1063 |
1020: Increased, induction of UDPGT's in liver |
1021: Increased, T4/T3 catabolism |
Nov 29, 2016 |
Dec 3, 2016 |
None
|
| 1127 |
1087: Increased, inflammation |
1032: Increased, secretion of local growth factors |
Nov 29, 2016 |
Dec 3, 2016 |
1 AOP
|